Skip to main content
. Author manuscript; available in PMC: 2018 Dec 15.
Published in final edited form as: Mucosal Immunol. 2018 Jun 15;11(5):1375–1385. doi: 10.1038/s41385-018-0048-x

Figure 7. Quantification of sinonasal inflammation, epithelial injury and goblet cell hyperplasia demonstrates the protective effect of Complement C3a Receptor deficiency and therapeutic antagonism.

Figure 7

(A). Inflammatory cell infiltrate, (B). Eosinophil accumulation, (C). Goblet cell hyperplasia, and (D). Epithelial injury/thickness. Data are expressed as mean ± SE; All statistical analysis are pairwise comparisons Control wildtype vs wildtype Af (#p<0.001), wildtype Af vs C3aR−/− Af (##p<0.01), wildtype Af vs C3aR i.n (*p<0.01), wildtype Af vs C3aR i.p. (**p< 0.01).